Pharma Pricing

The rapid development of pharmaceutical drugs has necessitated the rapid growth of export-oriented drugs and drugs. Investment in research production and pharmaceutical production is integrated into the network of suppliers and stock exchanges. Drug prices are subject to less environmental control, which is causing changes in the pharmaceutical sector. The risk of obtaining evidence of caution has ensured that the drugs are used properly.


  • Track 1-1 Cost-Benefit Analysis of Research Institutes and Business Sectors
  • Track 2-2 Partners and Stakeholders
  • Track 3-3 SWOT Analysing of Private and Government Agencies in the Pharma Industry
  • Track 4-4 Disaster Losses
  • Track 5-5 Patents and Risk of Manufactures

Related Conference of Pharmaceutical Sciences